The question marks surrounding P/K are both clear... P interim was never explained why it was cancelled? Also, there seems to be less enthusiasm reading the P press releases versus B-OM which are a few months apart from completing trials. Notice with P there's never any mention to interest/partners and so on... B-OM has had multiple clues to partnership... The concern with K is why it's taking so long to do a very tiny trial that should have been completed let alone waiting for interim data now? Leo's been quiet on K's progress. Could be financial concerns as well holding up K? Just because there's question marks doesn't mean the science won't succeed. ABSSSI is a prime example for being delayed due to costs.
News 
Market Data 
Discover 
AI
